Some apps are impractical to instrument directly, either because you don't control the code or they're written in a language that isn't easy to instrument with Prometheus. We must instead resort to ...
Q1 2026 Management view "We're off to a solid start to 2026 with first quarter revenue growth of 25% and adjusted EBITDA up approximately 15% versus the prior year," said CEO & Chairman Roderick de ...
Detailed price information for Biolife Solutions (BLFS-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results